vs
德康医疗(DXCM)与Sinclair, Inc.(SBGI)财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是Sinclair, Inc.的1.5倍($1.3B vs $836.0M),德康医疗净利率更高(21.2% vs 13.0%,领先8.2%),德康医疗同比增速更快(21.6% vs -16.7%),过去两年德康医疗的营收复合增速更高(12.0% vs 2.4%)
德康医疗是美国跨国医疗保健企业,专注于研发、生产及销售糖尿病管理领域的连续血糖监测(CGM)系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥,生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
辛克莱公司(以辛克莱广播集团开展业务)是一家上市的美国电信综合企业,由创始人朱利安·辛克莱·史密斯的后代控股。公司总部位于马里兰州巴尔的摩郊县科基斯维尔,按电视台数量计算是美国第二大电视台运营商,仅次于奈克斯达媒体集团,在全国100多个市场拥有或运营193家电视台,覆盖美国40%的区域。
DXCM vs SBGI — 直观对比
营收规模更大
DXCM
是对方的1.5倍
$836.0M
营收增速更快
DXCM
高出38.3%
-16.7%
净利率更高
DXCM
高出8.2%
13.0%
两年增速更快
DXCM
近两年复合增速
2.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.3B | $836.0M |
| 净利润 | $267.3M | $109.0M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | 9.6% |
| 净利率 | 21.2% | 13.0% |
| 营收同比 | 21.6% | -16.7% |
| 净利润同比 | 153.6% | -38.1% |
| 每股收益(稀释后) | $0.67 | $1.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DXCM
SBGI
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $836.0M | ||
| Q3 25 | $1.2B | $773.0M | ||
| Q2 25 | $1.2B | $784.0M | ||
| Q1 25 | $1.0B | $776.0M | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $994.2M | $917.0M | ||
| Q2 24 | $1.0B | $829.0M |
净利润
DXCM
SBGI
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $109.0M | ||
| Q3 25 | $283.8M | $-1.0M | ||
| Q2 25 | $179.8M | $-64.0M | ||
| Q1 25 | $105.4M | $-156.0M | ||
| Q4 24 | $151.7M | $176.0M | ||
| Q3 24 | $134.6M | $94.0M | ||
| Q2 24 | $143.5M | $17.0M |
毛利率
DXCM
SBGI
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率
DXCM
SBGI
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 9.6% | ||
| Q3 25 | 20.1% | 7.5% | ||
| Q2 25 | 18.4% | 2.7% | ||
| Q1 25 | 12.9% | 1.8% | ||
| Q4 24 | 17.0% | 26.5% | ||
| Q3 24 | 15.3% | 19.5% | ||
| Q2 24 | 15.7% | 7.7% |
净利率
DXCM
SBGI
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 13.0% | ||
| Q3 25 | 23.5% | -0.1% | ||
| Q2 25 | 15.5% | -8.2% | ||
| Q1 25 | 10.2% | -20.1% | ||
| Q4 24 | 13.6% | 17.5% | ||
| Q3 24 | 13.5% | 10.3% | ||
| Q2 24 | 14.3% | 2.1% |
每股收益(稀释后)
DXCM
SBGI
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.62 | ||
| Q3 25 | $0.70 | $-0.02 | ||
| Q2 25 | $0.45 | $-0.91 | ||
| Q1 25 | $0.27 | $-2.30 | ||
| Q4 24 | $0.37 | $2.64 | ||
| Q3 24 | $0.34 | $1.43 | ||
| Q2 24 | $0.35 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $866.0M |
| 总债务越低越好 | — | $4.4B |
| 股东权益账面价值 | $2.7B | $443.0M |
| 总资产 | $6.3B | $5.9B |
| 负债/权益比越低杠杆越低 | — | 9.84× |
8季度趋势,按日历期对齐
现金及短期投资
DXCM
SBGI
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $866.0M | ||
| Q3 25 | $1.8B | $526.0M | ||
| Q2 25 | $1.2B | $616.0M | ||
| Q1 25 | $904.9M | $631.0M | ||
| Q4 24 | $606.1M | $697.0M | ||
| Q3 24 | $621.2M | $536.0M | ||
| Q2 24 | $939.2M | $378.0M |
总债务
DXCM
SBGI
| Q1 26 | — | — | ||
| Q4 25 | — | $4.4B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | — | $4.1B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | — | $4.1B | ||
| Q3 24 | — | $4.1B | ||
| Q2 24 | — | $4.1B |
股东权益
DXCM
SBGI
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $443.0M | ||
| Q3 25 | $2.7B | $347.0M | ||
| Q2 25 | $2.6B | $361.0M | ||
| Q1 25 | $2.3B | $436.0M | ||
| Q4 24 | $2.1B | $583.0M | ||
| Q3 24 | $2.0B | $415.0M | ||
| Q2 24 | $2.4B | $340.0M |
总资产
DXCM
SBGI
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $5.9B | ||
| Q3 25 | $7.5B | $5.6B | ||
| Q2 25 | $7.3B | $5.7B | ||
| Q1 25 | $6.8B | $5.8B | ||
| Q4 24 | $6.5B | $5.9B | ||
| Q3 24 | $6.4B | $5.8B | ||
| Q2 24 | $6.8B | $5.7B |
负债/权益比
DXCM
SBGI
| Q1 26 | — | — | ||
| Q4 25 | — | 9.84× | ||
| Q3 25 | — | 11.75× | ||
| Q2 25 | — | 11.30× | ||
| Q1 25 | — | 9.56× | ||
| Q4 24 | — | 7.02× | ||
| Q3 24 | — | 9.86× | ||
| Q2 24 | — | 12.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $98.0M |
| 自由现金流经营现金流 - 资本支出 | — | $79.0M |
| 自由现金流率自由现金流/营收 | — | 9.4% |
| 资本支出强度资本支出/营收 | — | 2.3% |
| 现金转化率经营现金流/净利润 | — | 0.90× |
| 过去12个月自由现金流最近4个季度 | — | $115.0M |
8季度趋势,按日历期对齐
经营现金流
DXCM
SBGI
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $98.0M | ||
| Q3 25 | $659.9M | $-36.0M | ||
| Q2 25 | $303.0M | $122.0M | ||
| Q1 25 | $183.8M | $5.0M | ||
| Q4 24 | $301.4M | $198.0M | ||
| Q3 24 | $199.5M | $210.0M | ||
| Q2 24 | $279.4M | $-306.0M |
自由现金流
DXCM
SBGI
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $79.0M | ||
| Q3 25 | $579.4M | $-58.0M | ||
| Q2 25 | $208.9M | $105.0M | ||
| Q1 25 | $96.8M | $-11.0M | ||
| Q4 24 | $176.8M | $175.0M | ||
| Q3 24 | $88.3M | $193.0M | ||
| Q2 24 | $213.3M | $-329.0M |
自由现金流率
DXCM
SBGI
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 9.4% | ||
| Q3 25 | 47.9% | -7.5% | ||
| Q2 25 | 18.1% | 13.4% | ||
| Q1 25 | 9.3% | -1.4% | ||
| Q4 24 | 15.9% | 17.4% | ||
| Q3 24 | 8.9% | 21.0% | ||
| Q2 24 | 21.2% | -39.7% |
资本支出强度
DXCM
SBGI
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 2.3% | ||
| Q3 25 | 6.7% | 2.8% | ||
| Q2 25 | 8.1% | 2.2% | ||
| Q1 25 | 8.4% | 2.1% | ||
| Q4 24 | 11.2% | 2.3% | ||
| Q3 24 | 11.2% | 1.9% | ||
| Q2 24 | 6.6% | 2.8% |
现金转化率
DXCM
SBGI
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 0.90× | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | 1.13× | ||
| Q3 24 | 1.48× | 2.23× | ||
| Q2 24 | 1.95× | -18.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
SBGI
| Distribution Revenue | $384.0M | 46% |
| Core Advertising Revenue | $312.0M | 37% |
| Tennis Segment | $62.0M | 7% |
| Other | $40.0M | 5% |
| Other Media Non Media Revenuesand Intercompany Revenues | $24.0M | 3% |
| Political Advertising Revenue | $14.0M | 2% |